Community Center

Representation in rare disease care isn’t just about seeing yourself in the room. It changes everything: diagnosis, trust, and follow-through.When Black patients…

 Join us live to explore how ATTR-CM treatment success can be measured in clinical practice.Register here: https://ow.ly/XM8w50ZjBVXThis CME-accredited webinar…

Cardiomyopathy in Focus: Recognizing and Managing Cardiac Amyloidosis

AL amyloidosis can feel overwhelming — but understanding it doesn’t have to be. Join us to learn how the disease is diagnosed, what available treatment options and…

Atrial fibrillation affects up to 70% of patients with ATTR-CM—but how does it impact treatment outcomes?Dr. Brett Sperry and I discuss new findings showing that…

Heart Health Matters: Learn About ATTR-CM (ATTR-Cardiac Amyloidosis) ATTR-CM is a progressive condition caused by a buildup of abnormal proteins in the heart,…

Signs and Symptoms of Transthyretin Amyloid Cardiomyopathy (ATTR-CM). See link below 

Why HFpEF and ATTR-CM need greater visibility in heart failure pathways and policyWe talk a lot about the UK’s heart failure challenge.But less about how we can…

Caregiver support can make ATTR-CM appointments feel less overwhelming. In this video, advocate Quan Boatman shares how communication, shared planning, and tracking…

Hereditary ATTR amyloidosis affects the whole body, so care works best as a team. GI, rehab, genetics, and primary care each have a role.GI symptoms often show up…